Glenmark Pharmaceuticals Limited

NSE:GLENMARK.NS

1666.5 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Omzet 118,130.97127,254.33121,741.98108,060.26103,972.2897,050.8489,435.8188,638.1975,030.0665,215.7959,236.0550,123.4240,206.4329,490.725,006.46621,160.33220,092.00512,515.3367,575.8926,120.5323,806.606
Kosten van de omzet 78,634.1945,369.5444,597.0737,438.0737,666.3834,075.6731,095.6926,598.9423,971.4419,660.7719,121.6516,536.0213,453.979,918.3210,193.398,750.9976,757.9964,574.7123,817.3342,714.6751,793.191
Brutowinst 39,496.7881,884.7977,144.9170,622.1966,305.962,975.1758,340.1262,039.2551,058.6245,555.0240,114.433,587.426,752.4619,572.3814,813.07612,409.33513,334.0097,940.6243,758.5583,405.8572,013.415
Brutowinstmarge 0.3340.6430.6340.6540.6380.6490.6520.70.6810.6990.6770.670.6650.6640.5920.5860.6640.6340.4960.5560.529
Onderzoek- en ontwikkelingskosten 12,258.2912,500.3512,787.0813,186.9113,205.1214,480.2612,251.3312,622.338,175.96,014.425,998.064,115.5900772.758882.703757.73432.609263.344326.512248.073
Algemene en administratieve kosten 29,537.123,039.994,006.963,172.643,650.652,753.922,070.272,222.521,932.31,590.191,106.13815.98007,844.6626,976.79400000
Verkoop- en marketingkosten 5,157.1511,541.048,963.079,796.417,038.548,709.427,628.878,425.276,580.925,581.953,645.164,677.0800004,571.0183,245.1592,123.1611,521.8251,074.266
Verkoop-, algemene en administratieve kosten 33,362.5314,581.0312,970.0312,969.0510,689.1911,463.349,699.1410,647.798,513.227,172.144,751.2916,305.75007,844.6626,976.7944,571.0183,245.1592,123.1611,521.8251,074.266
Overige kosten 8,399.943,167.86688.35468.65162.93267.61129.59165.89280.42204.6448.464.8520,49513,191.27716.469-713.289258.593265.597104.141111.94776.268
Bedrijfskosten 33,362.5365,213.7758,744.2353,461.8353,485.0152,582.4745,706.3747,437.4539,578.5436,366.2431,278.4324,757.6120,49513,191.279,333.8897,146.2085,587.3413,943.3652,490.6461,960.2841,398.607
Bedrijfsresultaat 6,134.2516,671.0218,400.4817,160.3612,983.8215,898.6713,434.2614,794.0111,760.57,830.028,788.268,894.646,257.466,381.115,479.1873,858.3617,114.9883,613.1831,120.7161,272.942514.23
Bedrijfsresultaat ratio 0.0520.1310.1510.1590.1250.1640.150.1670.1570.120.1480.1770.1560.2160.2190.1820.3540.2890.1480.2080.135
Totaal overige inkomsten en kosten netto -5,769.3-7,986.51-3,988.02-3,335.61-2,023.06407.34-1,965.8-2,000.28-1,432.63-3,245.95-1,867.21-1,492.64-1,376.55-1,565.58-1,640.213-2,574.314-631.68-384.076-147.196-172.631-100.578
Inkomen voor belasting 364.958,684.5114,412.4613,824.7510,960.7612,579.8210,667.9512,601.5210,047.455,942.836,968.767,337.154,880.914,815.533,838.9742,688.8137,114.9883,613.1831,120.7161,272.942514.23
Inkomen voor belasting ratio 0.0030.0680.1180.1280.1050.130.1190.1420.1340.0910.1180.1460.1210.1630.1540.1270.3540.2890.1480.2080.135
Belastingkosten 18,673.454,910.514,475.974,123.873,201.063,663.122,925.123,442.313,028.41,190.431,512.731,107.15237.84237.2528.658754.084793.865512.583240.956201.531100.889
Nettowinst -15,016.682,972.459,417.119,700.387,759.78,916.597,741.919,159.677,020.984,753.15,422.756,147.434,643.074,578.333,310.3161,934.7296,321.3273,100.6879.761,071.411413.606
Nettowinstmarge -0.1270.0230.0770.090.0750.0920.0870.1030.0940.0730.0920.1230.1150.1550.1320.0910.3150.2480.1160.1750.109
WPA (Winst Per Aandeel) -53.2210.5333.3734.3827.531.627.4432.4625.0117.5220.0122.9117.0316.7812.47.725.812.993.644.491.76
Verwaterde WPA -53.2210.5333.3734.3827.531.627.4332.452517.522022.8917.0116.7612.47.524.911.563.214.081.75
EBITDA 11,953.3125,951.5624,934.3721,342.4318,588.5717,933.3917,088.4220,722.3514,527.7210,444.1311,022.6510,207.357,325.367,366.866,685.2917,459.5028,463.4634,419.8481,500.2561,609.805725.738
EBITDA ratio 0.1010.2040.2050.1980.1790.1850.1910.2340.1940.160.1860.2040.1820.250.2670.3530.4210.3530.1980.2630.191